fda shortage tirzepatide The has declared an end to the two-year of tirzepatide, the substance in the popular weight-loss medication Zepbound and the diabetes drug Mounjaro — meaning that far more people could FDA: Shortage of Weight Loss

Semaglutide and Better Lipid Profiles Unhealthy lipid levels, including high LDL cholesterol and triglycerides, are significant risk factors for cardiovascular disease

Some research indicates that tirzepatide's direct metabolic effects on liver and fat tissue function may improve lipid profiles even beyond what weight reduction alone would achieve, suggesting a dual benefit for heart health

Differences in inhibitory/facilitatory receptor locations within the 5-HT system may be involved

It was originally developed for people with arthritis

(center) the clinical Tensilon test, in which edrophonium injection transiently increases synaptic acetylcholine, producing brief improvement in muscle weakness in patients with myasthenia gravis

Nat Rev Cancer 8:96775 Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death